Pseudorabies virus DNA polymerase processivity factor pUL42 inhibits type I IFN production by negatively regulating cGAS-STING signaling pathway

Guangqiang Ye, Jian Gao, Haoxuan Cao, Xiaohong Liu, Hongyang Liu, Shanghui Wang, Yunfei Liu, Longfei Han, Qiongqiong Zhou, Yan-Dong Tang, Jin Tian, Liping Huang, Zun‐Ping Zhang, Changjiang WengJournal of Virology 2025 · DOI

TL;DR

Pseudorabies virus (PRV) employs a clever immune evasion strategy by using its DNA polymerase accessory protein, pUL42, to directly interfere with the host's innate immune sensor, cGAS. This interaction prevents cGAS from recognizing viral DNA, thereby shutting down the crucial type I interferon response and allowing the virus to replicate more effectively.

What Problem Does This Paper Address?

The innate immune system is our first line of defense against viral invaders. A key component of this defense against DNA viruses is the cGAS-STING signaling pathway, which detects viral DNA and triggers the production of type I interferons (IFNs). These IFNs then initiate a broad antiviral response. Pseudorabies virus (PRV), a significant pathogen in livestock, is known to have evolved various mechanisms to evade host immunity. However, the specific ways PRV proteins interact with and suppress the cGAS-STING pathway remained largely unknown. This study aimed to pinpoint which PRV proteins are involved in this immune evasion and to elucidate the molecular mechanisms behind this suppression.

Methods

The researchers employed a multi-pronged approach:

  • Screening: They screened 44 PRV-encoded proteins for their ability to inhibit IFN-β promoter activity, a key indicator of cGAS-STING pathway activation.
  • Reporter Assays: Luciferase reporter assays were used extensively to quantify the activity of IFN-β and other downstream IFN-stimulated genes (ISGs) under various conditions, including overexpression of PRV proteins and stimulation with dsDNA analogs.
  • Western Blotting: This technique was crucial for detecting protein expression levels, including the phosphorylation status of key signaling molecules like TBK1 and IRF3, which indicate pathway activation. It was also used to confirm the presence of PRV proteins and host factors.
  • qPCR: Quantitative PCR was used to measure the mRNA levels of IFN-β and ISGs, providing insights into the transcriptional regulation of the antiviral response.
  • Co-immunoprecipitation (Co-IP): This was a core technique to demonstrate direct physical interactions between PRV pUL42 and host proteins, particularly cGAS.
  • Confocal Microscopy: Used to visualize the subcellular localization of PRV proteins and host factors, helping to understand where these interactions occur.
  • RNA Interference (siRNA): Knocking down the expression of the ul42 gene allowed the researchers to assess the necessity of pUL42 for PRV's immune evasion and replication.
  • DNA Pull-down Assays: These experiments were designed to directly test whether pUL42 interferes with cGAS's ability to bind to viral DNA.
  • Mutagenesis: Truncated mutants of pUL42 and cGAS, as well as specific site-directed mutants of pUL42, were created to identify the functional domains involved in the interaction and inhibition.
  • Cell Culture and Viral Infection: Various cell lines (HEK293T, HeLa, PK15) and primary cells (PAMs) were used, along with PRV infection models, to study the pathway in relevant biological contexts.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • pUL42 is a direct antagonist of cGAS: The study definitively shows that PRV's pUL42 protein directly targets cGAS, a key sensor of viral DNA. This is a significant finding as it reveals a specific molecular mechanism for PRV's immune evasion.
  • Interference with DNA binding is key: pUL42 doesn't just broadly suppress the pathway; it specifically inhibits cGAS's ability to recognize and bind to double-stranded DNA (dsDNA). This is a critical step for cGAS activation.
  • Disruption of cGAS oligomerization: By preventing dsDNA binding, pUL42 also inhibits the dimerization and oligomerization of cGAS. This complex formation is essential for cGAS to produce the second messenger cGAMP, which then activates STING.
  • DNA-binding domain of pUL42 is crucial: The study identified specific arginine residues in pUL42 that are essential for its interaction with cGAS and its inhibitory function. This highlights the importance of pUL42's own DNA-binding capabilities in its interaction with cGAS.
  • Cytoplasmic localization is important: pUL42 functions in the cytoplasm, where cGAS typically resides and encounters viral DNA. This localization is critical for its inhibitory action.
  • pUL42 promotes viral replication: Knocking down pUL42 expression led to increased type I IFN production and significantly reduced PRV replication, underscoring pUL42's role in facilitating viral spread.

Key Results

  • Screening identified pUL42 as a potent inhibitor: Out of 44 PRV proteins screened, pUL42 was identified as a strong inhibitor of cGAS-STING-induced IFN-β promoter activity.
  • pUL42 suppresses multiple IFN-related promoters: Overexpression of pUL42 inhibited the activity of IFN-β, ISG56, ISG54, ISRE, and NF-κB promoters.
  • pUL42 reduces IFN mRNA and protein levels: In cells stimulated with dsDNA analogs or infected with PRV, pUL42 overexpression significantly decreased the mRNA levels of Ifnb1, Ifna4, and ISGs.
  • pUL42 inhibits TBK1 and IRF3 phosphorylation: This indicates that pUL42 acts upstream of these key signaling kinases in the cGAS-STING pathway.
  • pUL42 directly interacts with cGAS: Co-IP experiments confirmed a physical interaction between pUL42 and cGAS, but not with STING, TBK1, or IRF3.
  • pUL42's DNA-binding sites are essential for cGAS interaction: Mutating key residues in pUL42's DNA-binding domain abolished its ability to interact with cGAS and inhibit IFN production.
  • pUL42 inhibits cGAS binding to dsDNA: DNA pull-down assays showed that pUL42, but not its DNA-binding mutant, prevented cGAS from binding to PRV genomic DNA and poly(dA:dT).
  • pUL42 inhibits cGAS dimerization and oligomerization: Co-IP and Western blot analyses demonstrated that pUL42 suppressed cGAS dimerization and oligomerization, both in vitro and during PRV infection.
  • Knockdown of pUL42 enhances IFN production and reduces viral titer: siRNA-mediated knockdown of ul42 in PRV-infected cells led to increased IFN production and significantly reduced viral titers.

Limitations and Future Work

  • In vivo relevance: While the study used various cell lines and primary cells, further in vivo studies would be beneficial to fully understand the role of pUL42 in the context of a whole organism.
  • Other PRV proteins: The study focused on pUL42, but PRV has other immune evasion proteins. Investigating potential synergistic or additive effects with other PRV proteins could provide a more complete picture of PRV's immune evasion strategies.
  • Mechanism of pUL42's DNA-binding domain interaction with cGAS: While the study identified the importance of pUL42's DNA-binding sites for cGAS interaction, the precise molecular details of how these sites engage with cGAS remain to be fully elucidated.
  • Therapeutic targets: The authors suggest that pUL42's role in viral replication and immune evasion makes it a potential target for anti-PRV drugs or attenuated live vaccines. Future work could explore strategies to inhibit pUL42 function.

Summary updated

Abstract

Cyclic GMP-AMP synthase (cGAS)-stimulator of interferon gene (STING) axis is essential for host resistance to DNA virus infections by regulating type I interferon production. However, whether pseudorabies virus (PRV) antagonizes the cGAS-STING signaling pathway to immune evasion is not fully investigated. In this study, we clearly demonstrated that the PRV pUL42 protein inhibits the recognition of double-stranded DNA of cGAS, leading to inhibiting the oligomerization and activation of cGAS, thereby suppressing the cGAS-mediated host antiviral immune responses. Taken together, our results reveal a novel strategy employed by PRV to evade host defenses, which will provide theoretical support for the development of anti-PRV drugs for the prevention and control of PRV.
BibTeX
@article{ye2025pseudorabies,
  author = {Guangqiang Ye and Jian Gao and Haoxuan Cao and Xiaohong Liu and Hongyang Liu and Shanghui Wang and Yunfei Liu and Longfei Han and Qiongqiong Zhou and Yan-Dong Tang and Jin Tian and Liping Huang and Li Huang and Zun‐Ping Zhang and Changjiang Weng},
  title = {{Pseudorabies virus DNA polymerase processivity factor pUL42 inhibits type I IFN production by negatively regulating cGAS-STING signaling pathway}},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.01218-25},
}
Figure